These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25203185)

  • 1. Valuation of hospital bed-days released by infection control programs: a comparison of methods.
    Stewardson AJ; Harbarth S; Graves N;
    Infect Control Hosp Epidemiol; 2014 Oct; 35(10):1294-7. PubMed ID: 25203185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is a hospital bed day worth? A contingent valuation study of hospital Chief Executive Officers.
    Page K; Barnett AG; Graves N
    BMC Health Serv Res; 2017 Feb; 17(1):137. PubMed ID: 28196489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How patient volume affects non-salary expenses.
    Hosp Mater Manage; 1997 Apr; 22(4):18-9. PubMed ID: 10166688
    [No Abstract]   [Full Text] [Related]  

  • 4. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
    Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
    J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital occupancy costs.
    Health Estate; 1999 Feb; 53(1):27. PubMed ID: 10387923
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for calculating costs of hospital-acquired infections: an Italian experience.
    Gianino MM; Vallino A; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    J Health Organ Manag; 2007; 21(1):39-53. PubMed ID: 17455811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
    Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
    J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of inefficiency in US hospitals, 1985-1997.
    Shah BR; Reed SD; Francis J; Ridley DB; Schulman KA
    J Health Care Finance; 2003; 30(1):1-9. PubMed ID: 12967239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bed occupancy, turnover intervals and MRSA rates in English hospitals.
    Cunningham JB; Kernohan WG; Rush T
    Br J Nurs; 2006 Jun 22-Jul 12; 15(12):656-60. PubMed ID: 16835541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data trends. Factors influencing nursing unit costs.
    Healthc Financ Manage; 1997 Jan; 51(1):95. PubMed ID: 10163902
    [No Abstract]   [Full Text] [Related]  

  • 13. How much does excess inpatient capacity really cost?
    Sopariwala PR
    Healthc Financ Manage; 1997 Apr; 51(4):54-8, 60, 62. PubMed ID: 10166279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dollars and sense in the intensive care unit: the costs of ventilator-associated pneumonia.
    Shorr AF; Wunderink RG
    Crit Care Med; 2003 May; 31(5):1582-3. PubMed ID: 12771639
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB; Di Stefano L; Noah N
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertain demand, the structure of hospital costs, and the cost of empty hospital beds.
    Gaynor M; Anderson GF
    J Health Econ; 1995 Aug; 14(3):291-317. PubMed ID: 10145137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profit and loss analysis for an intensive care unit (ICU) in Japan: a tool for strategic management.
    Cao P; Toyabe S; Abe T; Akazawa K
    BMC Health Serv Res; 2006 Jan; 6():1. PubMed ID: 16403235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients.
    Plowman R; Graves N; Esquivel J; Roberts JA
    J Hosp Infect; 2001 May; 48(1):33-42. PubMed ID: 11358469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.